Merck sues federal government, calling plan to negotiate Medicare drug prices 'extortion'
Merck is suing the federal government over a plan to negotiate Medicare drug prices, calling the program a sham equivale...
Merck is suing the federal government over a plan to negotiate Medicare drug prices, calling the program a sham equivale...
Shares of Merck and Moderna jumped early Tuesday after the drugmakers said a potential skin cancer vaccine they are deve...
Merck turned in a better-than-expected third quarter and raised its 2022 forecast as the drugmaker’s top seller brought...
Better-than-expected sales of its COVID-19 treatment and the cancer blockbuster Keytruda helped push Merck past analyst...
The blockbuster cancer treatment Keytruda pushed Merck past fourth-quarter expectations, and the drugmaker’s COVID-19 tr...
India has not added Merck's pill to the list of treatments for Covid due to 'major safety concerns', a top health offici...
Japan has approved the COVID-19 pill developed by U.S. pharmaceutical company Merck & Co. for use beginning next week
The FDA on Thursday authorized a Merck pill for COVID-19 treatment following authorization of a Pfizer pill on Wednesday...
U.S. regulators have authorized a second pill against COVID-19, an antiviral drug from Merck that may help blunt the wav...
The European Medicines Agency says it has received a request from Merck to authorize its coronavirus antiviral, the firs...